Klaus Kopka: h-index, Total Citations, and Citation Map
Klaus Kopka's h-index is 70 (214 i10-index, 22,754+ total citations across 100+ publications) according to Google Scholar as of June 2026. Klaus Kopka is affiliated with Professor of Bioinorganic and Radiopharmaceutical Chemistry, Technical University Dresden (TUD.
Klaus Kopka is a researcher affiliated with Professor of Bioinorganic and Radiopharmaceutical Chemistry, Technical University Dresden (TUD, specializing in Radiopharmaceutical Sciences. Their work has been cited 22,754 times. This profile visualizes their global influence, spanning a global audience.
Klaus Kopka's Citation Metrics
Bibliometric impact based on 100 indexed publications.
- H-Index
- 70
- i10-Index
- 214
- Total Citations
- 22,754
- Citing Countries
- 0
As of June 2026.
Klaus Kopka has an h-index of 70 and 22,754 total citations across 100 publications, with research cited by institutions in 0 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Klaus Kopka's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 22,754 citations for Klaus Kopka
We've shown the most-cited 5,000. Unlock the full crawl (22,704 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer
20161,354
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Klaus Kopka's research
Klaus Kopka is a researcher in Radiopharmaceutical Sciences at Professor of Bioinorganic and Radiopharmaceutical Chemistry, Technical University Dresden (TUD. Their work has been cited 22,754 times across 100 publications (h-index 70), according to Google Scholar.
Their most-cited work, “225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer” (2016), has accumulated 1,354 citations. Other influential works include “The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer” (2015) with 1,203 citations and “68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0” (2017) with 919 citations.
